Xanthohumol and tetrahydro-isoalpha acid based protein kinase modulation cancer treatment
US7736677B2 · kind B2 · utility
7Cited by
2References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 20, 2007 |
| Grant date | Jun 15, 2010 |
| Priority date | — |
| Expiry date | Jun 20, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds and methods for protein kinase modulation for cancer treatment are disclosed. The compounds and methods disclosed are based on xanthohumol or isoxantohumol, or tetrahydro-isoalpha acids commonly found in hops.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.